Heart and Voice: smartphone voice monitoring for heart health
Official title: Evaluation of Voice and ECG Transmission and AI Models Using Voice, ECG and Health Data Collected Using a Mayo Clinic Center for Digital Health (CDH)-Developed App for a Repository: Mayo Clinic CV Research for Heart & Voice Study
Run by Mayo Clinic · NCT07224685 · Data updated 2026-11-12
We will try to see if short voice recordings from adults' smartphones (and Apple Watches when available) can detect cardiovascular disease or changes in heart health.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000000 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | March 5, 2024 |
| Main results expected | March 2029 |
| Study ends | March 2029 |
| Registry record updated | November 5, 2025 |
| Trial ID | NCT07224685 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adult Mayo Clinic patients who are interested, can sign HIPAA authorization, and who use the Mayo patient iPhone app on iOS 14+ with an Apple Watch v4+ (not SE), or who have an Android phone capable of recording voice.
✕Probably not a fit
People under 18, those without a compatible smartphone or unwilling to share voice data or HIPAA authorization, and individuals whose voice recordings are unusable (for example due to severe voice disorders) may not receive benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project enrolls consenting Mayo Clinic patients who provide voice recordings using their own iPhone (iOS 14+) or Android device and may pair Apple Watch v4+ data when available. Recorded voice signals will be processed with signal‑processing and machine‑learning methods to identify features associated with cardiovascular disease, wellness, or elevated health risk. There is no drug or procedure intervention; the study collects remote digital data with signed HIPAA authorization. Researchers will compare voice-derived features to clinical information in the medical record to determine correlations with heart health.
Why it matters
Potential benefit: If successful, this could offer a low-cost, noninvasive way to monitor heart health remotely and alert people who need clinical follow-up.
How similar studies have gone: Prior exploratory studies have shown promising links between voice features and cardiopulmonary conditions, but the approach remains experimental and not yet validated for routine clinical use.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients using the Mayo patient iPhone app and iOS 14.0 or later (determined automatically via Mayo software) and Apple Watch v 4 or later (not SE), or if they have Android device for voice * Expressed interest in participation * Signed HIPPA authorization Exclusion Criteria: • Age under 18
Where it's running
-
Mayo Clinic in Rochester
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Paul Friedman, M.D. — Mayo Clinic
- Study coordinator: Amanda Priebe
- Email: priebe.amanda@mayo.edu
- Phone: 507-422-6932
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
-
Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients
This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.
-
One-stop photon-counting CT for patients after PCI
This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.